Celecoxib Capsules 1.2g – Grade COX?2 Inhibitor

Celecoxib Capsules 1.2g – Grade COX?2 Inhibitor

$1.00

Celecoxib is a selective COX?2 inhibitor (NSAID) commonly used in preclinical research to study inflammation, pain, cancer prevention, and cardiovascular risk. Each capsule contains 200?mg celecoxib. ?? For laboratory research use only.?Please consult the staff for other purposes?

EMI starting from $0.00/month - View Plans
Compare

描述

Product Specifications

Attribute Details
Product Name Celecoxib Capsules
Generic Name Celecoxib
CAS Number 169590?42?5
Molecular Formula C??H??F?N?O?S
Molecular Weight ~381.37?g/mol
Dosage Form Oral capsule
Strength 200?mg per capsule
Pack Size (e.g., 30 capsules)
Manufacturing Approval N/A (research grade)
Manufacturer Sichuan Xinston Pharmaceutical
Storage Store at 15–25?°C, protect from moisture and light
Intended Use Laboratory research use only

Mechanism of Action

Celecoxib selectively inhibits cyclooxygenase?2 (COX?2), reducing prostaglandin synthesis involved in inflammation, pain, and fever—while sparing COX?1, reducing gastrointestinal side effects in research models.
zh.wikipedia.orgaccessdata.fda.gov+2de.wikipedia.org+2zh.wikipedia.org+2dailymed.nlm.nih.govncbi.nlm.nih.gov+1medcentral.com+1


Research Applications & Pharmacology

  • Inflammation & pain models: Used in osteoarthritis, rheumatoid arthritis, nociceptive pain, and dysmenorrhea studies.

  • Cancer/prevention models: Investigated for chemoprevention in familial adenomatous polyposis and COX?2?dependent tumor biology (e.g., colorectal, neuroblastoma).

  • Cardiovascular risk profiling: Employed in studies assessing thrombotic risk and COX?2 inhibitor safety.

  • Pharmacokinetics: Well absorbed, peak plasma 2–4 hrs, half-life ~6–12 hrs, highly protein?bound (~97%), metabolized by CYP2C9/CYP3A4 to inactive metabolites excreted in urine/feces.


Safety Profile & Handling

Common adverse effects (clinical/preclinical context):

  • GI: bleeding, ulceration, perforation

  • Cardiovascular: increased risk of MI and stroke

  • Others: headache, dizziness, hypertension, renal and hepatic effects

Lab handling recommendations:

  • Use personal protective equipment and follow standard handling for NSAIDs.

  • Monitor study models for GI, cardiovascular, renal, and hepatic markers.

  • Use lowest effective dose for shortest duration.

  • Dispose of unused material as chemical waste.


?? Research?Use Disclaimer

This product is intended solely for laboratory research, and is not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may pose safety risks and compromise data integrity.

其他信息

重量 1.1 公斤
尺寸 16 × 18 × 16 厘米

评价

目前还没有评价

成为第一个“Celecoxib Capsules 1.2g – Grade COX?2 Inhibitor” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare